Evaxion Biotech A/S
Evaxion Biotech A/S (EVAX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EVAX · as of Jun 9, 2026
Key Statistics
Explore Evaxion Biotech A/S Data
evax stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The EVAX analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $9.50, representing +154.69% upside from the current price of $3.73.
Competitors & Peers
evax competitorsEVAX
ANVS
BCAB
BTAI
CELU
GBIOStock Performance
Full HistoryAbout Evaxion Biotech A/S
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and vira…
what is evaxion biotech a/s · evax stock overview · evaxion biotech a/s company profile · who is evaxion biotech a/s ceo · evax NASDAQ · evaxion biotech a/s headquarters · evaxion biotech a/s business segments
About Stock Overview & Key Data
Evaxion Biotech A/S (EVAX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 5, 2021. As of the latest trading session, EVAX stock price is $3.73, with a market capitalization of $23.6M. The stock has returned +23.92% over the past 12 months and -21.80% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Evaxion Biotech A/S stock is Buy, with an average 12-month price target of $9.50. In fiscal year 2025, Evaxion Biotech A/S reported revenue of $7.5M and net income of -$7.7M. For detailed data — including Evaxion Biotech A/S revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Evaxion Biotech A/S (EVAX) stock price is $3.73. The stock is traded on NASDAQ under the ticker symbol EVAX. The 52-week range is $2.07 – $12.15.